Progressive Disease Clinical Trials

14 clinical trials for Progressive Disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET — RECRUITING · PHASE2
• First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma — RECRUITING · PHASE1
• Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT — RECRUITING · NA
• Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE1
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma — TERMINATED · PHASE2
• Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer — COMPLETED · NA
• Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma — COMPLETED · PHASE2
• Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies — ACTIVE_NOT_RECRUITING · PHASE1
• Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma — WITHDRAWN · PHASE1
• Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer — TERMINATED · PHASE1
• sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer — OTHER · PHASE2
• CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome — WITHDRAWN · PHASE1
• Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive — COMPLETED · PHASE2

Refine this search